Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.

6011Background: This phase Ib clinical trial was performed to investigate an agonistic murine antibody to OX40 (MEDI6469) at various dose intervals prior to definitive surgical resection in patient...